Zolendronate (zometa).
D001862:Bone Resorption / Q000517:prevention & control; D004164:Diphosphonates / Q000009:adverse effects / Q000493:pharmacokinetics / Q000652:urine; D004305:Dose-Response Relationship, Drug; D005252:Fees, Pharmaceutical; D006207:Half-Life; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000493:pharmacokinetics / Q000652:urine; D000077211:Zoledronic Acid
D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid